Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pre-mRNA processing factor 4 kinase (PRP4K) is a highly conserved, essential serine/threonine kinase involved in the phosphorylation of core spliceosomal proteins to facilitate formation and activation of the spliceosome B complex during pre-mRNA splicing[1][2][3][5]. Beyond splicing, PRP4K coordinates additional cell functions including regulation of transcription (through chromatin remodeling complexes), control of the spindle assembly checkpoint and cell division, and negative regulation of oncogenic YAP signaling. PRP4K acts as a tumor suppressor; its reduction or haploinsufficiency confers cancer cell resistance to taxane chemotherapy and promotes more aggressive disease, particularly in breast and ovarian cancer, making it a potential biomarker for drug response and prognosis[1]. PRP4K’s broad cellular roles, including links to neurodegeneration and sensitivity to mitotic stress, highlight its central role in genome maintenance and cell fate regulation[1][3].
Not applicable (no direct drug targeting described); as a kinase, mechanistic rationale for inhibition would be to block phosphorylation of splicing and checkpoint proteins to affect mitosis or splicing in cancer cells[1][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pre-mRNA processing factor 4 kinase (PRP4K).